Targeted Radionuclide Dosimetrist

The clinical workflow represents personalized precision medicine at the cellular level. Conforming to European Association of Nuclear Medicine EANM Dosimetry Committee guidelines and Medical Internal Radiation Dose MIRD principles, the dosimetrist performs quantitative post therapeutic SPECT/CT imaging at multiple timepoints following infusion. The specialist reconstructs absolute radioactivity concentrations, aligns multi timepoint 3D scans using deformable image registration, and integrates time activity curves across tumors, bone marrow, and critical dose limiting organs including kidneys and salivary glands.

By fitting multi exponential clearance models to organ residence times, the dosimetrist calculates cumulative absorbed doses in grays per gigabecquerel. This enables oncologists to maximize radiation dose to malignant tumors while guaranteeing that normal kidneys receive less than the twenty three gray clinical tolerance threshold. While AI segmentation tools and automated voxel dosimetry engines accelerate organ contouring, untangling physiological tracer clearance from patient hydration changes, correcting for partial volume effects in small tumors, and personalizing treatment cycles demand certified human internal radiation dosimetrists.

At 08:00, the dosimetrist logs into the theranostics computing workstation to analyze multi timepoint imaging for a sixty eight year old prostate cancer patient undergoing cycle three of Lutetium 177 PSMA 617 therapy. The patient received 7.4 gigabecquerels of Lutetium 177 seventy two hours ago, followed by quantitative SPECT/CT scans at four, twenty four, and seventy two hours post infusion. The dosimetrist imports the three tomographic studies into MIM SurePlan, utilizing rigid and deformable registration algorithms to align the organ boundaries across all timepoints. The dosimetrist carefully segments the kidney renal cortex, spleen, and seven major pelvic bone metastases, correcting

for partial volume effects where small tumor nodules under report radioactivity concentration. Plotting time activity curves for both kidneys, the dosimetrist fits a bi exponential clearance curve in MATLAB, calculating an effective biological clearance half life of thirty six hours. Utilizing the MIRD formalism with patient specific organ mass adjustments derived from CT volumes, the dosimetrist calculates that the right kidney absorbed 2.4 grays and the left kidney absorbed 2.2 grays during this cycle. Summing the cumulative dose across all three cycles brings total renal exposure to 14.1 grays, safely.

A Targeted Radionuclide Therapy Lutetium Dosimetrist calculates, models, verifies, and personalizes absorbed radiation doses delivered to metastatic tumors and critical organs during molecular targeted radionuclide therapy. Operating within cutting edge theranostics cancer centers and nuclear medicine departments, the dosimetrist specializes in administering beta emitting therapeutic radiopharmaceuticals such as Lutetium 177 PSMA for metastatic castration resistant prostate cancer and Lutetium 177 DOTATATE for advanced neuroendocrine tumors.

Core responsibilities include calculate patient personalized absorbed radiation doses from lutetium 177 and actinium 225 cancer therapies., operational coordination, and ensuring strict adherence to Kenyan statutory frameworks and quality standards.

Key organizations hiring for this role include Kenya Nuclear Regulatory Authority KNRA, Kenyatta University Teaching Research and Referral Hospital KUTRRH, Kenyatta National Hospital KNH Cancer Centre, Aga Khan University Hospital Nairobi Oncology Division, alongside expanding opportunities in Nairobi, Mombasa, Kisumu, and regional infrastructure projects.

Targeted Radionuclide Dosimetrist Specialist, Senior Targeted Radionuclide Dosimetrist, Targeted Radionuclide Dosimetrist Lead, Targeted Radionuclide Dosimetrist Consultant

By fitting multi exponential clearance models to organ residence times, the dosimetrist calculates cumulative absorbed doses in grays per gigabecquerel. This enables oncologists to maximize radiation dose to malignant tumors while guaranteeing that normal kidneys receive less than the twenty three gray clinical tolerance threshold. While AI segmentation tools and automated voxel dosimetry engines accelerate organ contouring, untangling physiological tracer clearance from patient hydration changes, correcting for partial volume effects in small tumors, and personalizing treatment cycles demand certified human internal radiation dosimetrists. Employment opportunities concentrate across major industrial, commercial, and financial hubs including Nairobi, Mombasa, Kisumu, Nakuru, and Eldoret, alongside specialized regional project sites.